Compare Stocks

→ “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MQR Monarques Gold	C$0.23 -8.0%	C$0.23	C$0.15 ▼ C$0.42	C$53.60M	N/A	128,788 shs	196,500 shs
PRIM Primoris Services	$50.16 +4.9%	$43.62	$23.70 ▼ $52.75	$2.69B	1.14	502,911 shs	1.14 million shs
VM Voyageur Pharmaceuticals	C$0.06 +10.0%	C$0.06	C$0.04 ▼ C$0.09	C$7.64M	0.49	92,755 shs	25,000 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MQR Monarques Gold	0.00%	0.00%	0.00%	0.00%	0.00%
PRIM Primoris Services	+4.96%	+6.20%	+9.42%	+33.94%	+104.57%
VM Voyageur Pharmaceuticals	+10.00%	0.00%	-21.43%	-26.67%	-15.38%

Elon’s New Device is About to Shock the World (Ad)

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MQR Monarques Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PRIM Primoris Services	3.0304 of 5 stars	1.3	0.0	1.7	3.2	3.1	2.5	3.1
VM Voyageur Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MQR Monarques Gold	N/A	N/A	N/A	N/A
PRIM Primoris Services	2.67	Moderate Buy	$53.67	6.99% Upside
VM Voyageur Pharmaceuticals	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest VM, MQR, OGX, PRIM, and PWN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/5/2024	PRIM Primoris Services	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$44.00 ➝ $63.00
4/4/2024	PRIM Primoris Services	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$38.00 ➝ $43.00
4/4/2024	PRIM Primoris Services	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$45.00 ➝ $55.00
2/29/2024	PRIM Primoris Services	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$34.00 ➝ $38.00
2/28/2024	PRIM Primoris Services	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$40.00 ➝ $45.00

(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MQR Monarques Gold	C$30.13M	1.78	C$0.07 per share	3.54	C$0.18 per share	1.31
PRIM Primoris Services	$5.72B	0.47	$5.20 per share	9.64	$23.17 per share	2.16
VM Voyageur Pharmaceuticals	N/A	N/A	C$0.00 per share	35.00	C$0.01 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MQR Monarques Gold	N/A	-C$0.02	N/A	∞	N/A	N/A	N/A	N/A	N/A
PRIM Primoris Services	$126.14M	$2.32	21.62	15.63	N/A	2.21%	13.20%	4.16%	8/5/2024 (Estimated)
VM Voyageur Pharmaceuticals	-C$1.35M	-C$0.01	N/A	∞	N/A	N/A	-71.00%	-27.95%	N/A

Latest VM, MQR, OGX, PRIM, and PWN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2024	Q1 2024	PRIM Primoris Services	$0.08	$0.47	+$0.39	$0.59	$1.38 billion	$1.41 billion
2/26/2024	Q4 2023	PRIM Primoris Services	$0.64	$0.85	+$0.21	$1.01	$1.55 billion	$1.52 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MQR Monarques Gold	N/A	N/A	N/A	N/A	N/A
PRIM Primoris Services	$0.24	0.48%	N/A	10.34%	N/A
VM Voyageur Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Latest VM, MQR, OGX, PRIM, and PWN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/21/2024	PRIM Primoris Services	quarterly	$0.06	0.6%	3/27/2024	3/28/2024	4/15/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MQR Monarques Gold	19.15	1.52	1.22
PRIM Primoris Services	0.72	1.41	1.41
VM Voyageur Pharmaceuticals	2.54	0.48	0.84

Ownership

Institutional Ownership

Company	Institutional Ownership
MQR Monarques Gold	N/A
PRIM Primoris Services	91.82%
VM Voyageur Pharmaceuticals	N/A

Insider Ownership

Company	Insider Ownership
MQR Monarques Gold	N/A
PRIM Primoris Services	1.30%
VM Voyageur Pharmaceuticals	10.21%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MQR Monarques Gold	N/A	233.03 million	N/A	Not Optionable
PRIM Primoris Services	14,058	53.62 million	52.92 million	Optionable
VM Voyageur Pharmaceuticals	N/A	138.81 million	N/A	Not Optionable

VM, MQR, OGX, PRIM, and PWN Headlines

Source	Headline
	Voyageur Pharmaceuticals executes royalty agreement with Rain Cage Carbon proactiveinvestors.com - March 13 at 8:07 PM
	Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development thenewswire.com - March 13 at 3:07 PM
	Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement thenewswire.com - March 4 at 12:38 PM
	Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement thenewswire.com - March 1 at 10:56 AM
	Voyageur Pharmaceuticals Ltd. Announces Private Placement thenewswire.com - January 16 at 12:54 PM
	Voyageur Pharmaceuticals Ltd VM morningstar.com - January 3 at 11:17 PM
	Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors stockhouse.com - December 21 at 7:10 PM
	Voyageur Pharmaceuticals has a really interesting programme for 2024 — Proactive Research proactiveinvestors.co.uk - December 21 at 2:09 PM
	Voyageur Pharmaceuticals Initiates International Expansion thenewswire.com - December 14 at 5:59 PM
	Closing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM) theglobeandmail.com - December 8 at 12:35 AM
	Closing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM) theglobeandmail.com - October 24 at 12:33 AM
	Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media stockhouse.com - September 14 at 1:17 PM
	Voyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast media proactiveinvestors.com - September 14 at 1:17 PM
	Closing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM) theglobeandmail.com - September 7 at 8:29 AM
	Closing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM) theglobeandmail.com - June 20 at 9:07 PM
	Voyageur Pharmaceuticals completes field work at Frances Creek project in British Columbia proactiveinvestors.com - May 31 at 3:13 PM
	Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs finance.yahoo.com - May 24 at 10:27 AM
	Voyageur Pharmaceuticals unveils pioneering agreement with Rain Cage Carbon proactiveinvestors.com - May 24 at 10:27 AM
	Closing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM) theglobeandmail.com - May 10 at 2:29 PM
	Closing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM) theglobeandmail.com - May 4 at 12:58 AM
	Closing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM) theglobeandmail.com - May 2 at 12:14 AM
	Closing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM) theglobeandmail.com - April 29 at 4:26 PM
	Closing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM) theglobeandmail.com - April 28 at 6:06 PM
	Closing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM) theglobeandmail.com - April 26 at 2:36 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Monarques Gold

CVE:MQR

Monarques Gold Corporation engages in the acquisition, exploration, and development of mining properties in Canada. The company has approximately 240 square kilometers of gold properties, including the Beaufor Mine; the Croinor Gold and Wasamac advanced projects; and the Camflo and Beacon mills, as well as 6 promising exploration projects located in the Val-d'Or area, Quebec. It also offers toll milling services through its 1,200 tpd Camflo mill. The company was formerly known as Monarques Resources Inc. and changed its name to Monarques Gold Corporation in January 2015. Monarques Gold Corporation was incorporated in 2011 and is headquartered in Saint-Sauveur, Canada.

Primoris Services

NASDAQ:PRIM

Primoris Services Corporation, a specialty contractor company, provides a range of specialty construction, fabrication, maintenance, replacement, and engineering services in the United States and Canada. The company operates through Utilities and Energy/Renewables segments. The Utilities segment offers installation and maintenance services for new and existing natural gas distribution systems, electric utility distribution and transmission systems, and communications systems. The Energy/Renewables segment provides a range of services, including engineering, procurement, and construction, as well as retrofits, highway and bridge construction, demolition, site work, soil stabilization, excavation, flood control, upgrades, repairs, outages, and maintenance services to renewable energy and energy storage, renewable fuels, petroleum, and petrochemical industries, as well as state departments of transportation. It also offers pipeline construction and maintenance, and storage services; pipeline facility, and integrity services. Primoris Services Corporation was founded in 1960 and is headquartered in Dallas, Texas.

Voyageur Pharmaceuticals

CVE:VM

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial